We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
AUM
$84.2M
AUM Growth
+$472K
Cap. Flow
+$1.64M
Cap. Flow %
1.94%
Top 10 Hldgs %
44.61%
Holding
75
New
3
Increased
26
Reduced
8
Closed
13

Top Buys

Rank Stock Value
1
SABR icon
Sabre
SABR
+$1.72M
2
WKC icon
World Kinect Corp
WKC
+$1.36M
3
BRKL
Brookline Bancorp
BRKL
+$1.26M
4
ALCO icon
Alico
ALCO
+$641K
5
OSPN icon
OneSpan
OSPN
+$599K

Sector Composition

Rank Sector Weight
1 Healthcare 36.45%
2 Industrials 11.96%
3 Energy 9.91%
4 Financials 9.6%
5 Consumer Discretionary 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALCO icon
1
Alico
ALCO
$300M
$5.2M 6.18%
215,000
+25,000
+13% +$641K
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
$4.99M 5.93%
450,000
NHC icon
3
National Healthcare
NHC
$3.49B
$4.36M 5.17%
75,000
+10,000
+15% +$575K
TGB
4
Trekor Metals
TGB
$3.36B
$4.15M 4.93%
2,500,000
RLGT icon
5
Radiant Logistics
RLGT
$408M
$3.67M 4.36%
560,000
+15,000
+3% +$83.9K
PLPC icon
6
Preformed Line Products
PLPC
$1.98B
$3.58M 4.26%
28,000
BGC icon
7
BGC Group
BGC
$5.76B
$3.4M 4.04%
650,000
-25,000
-4% -$115K
ARKR icon
8
Ark Restaurants
ARKR
$19.8M
$3.26M 3.87%
184,607
SWN
9
DELISTED
Southwestern Energy Company
SWN
$2.5M 2.97%
500,000
TALO icon
10
Talos Energy
TALO
$2.78B
$2.45M 2.91%
165,000
+10,000
+6% +$172K
NMRK icon
11
Newmark Group
NMRK
$2.87B
$2.3M 2.73%
325,000
RIGL icon
12
Rigel Pharmaceuticals
RIGL
$868M
$1.98M 2.35%
150,000
IMGN
13
DELISTED
Immunogen Inc
IMGN
$1.92M 2.28%
500,000
DRRX
14
DELISTED
DURECT Corp
DRRX
$1.81M 2.15%
400,000
+25,000
+7% +$136K
AMSC icon
15
American Superconductor
AMSC
$1.38B
$1.72M 2.04%
350,000
+20,000
+6% +$100K
ARKO icon
16
ARKO Corp
ARKO
$490M
$1.61M 1.92%
190,000
CTSO icon
17
Cytosorbents Corp
CTSO
$21.1M
$1.52M 1.8%
450,000
-25,000
-5% -$75K
CLPT icon
18
ClearPoint Neuro
CLPT
$474M
$1.48M 1.75%
175,000
+23,190
+15% +$203K
TAST
19
DELISTED
Carrols Restaurant Group, Inc.
TAST
$1.39M 1.66%
625,000
CHRS icon
20
Coherus Oncology
CHRS
$218M
$1.37M 1.62%
200,000
+25,000
+14% +$194K
BRKL
21
DELISTED
Brookline Bancorp
BRKL
$1.31M 1.56%
125,000
+100,000
+400% +$1.26M
SABR icon
22
Sabre
SABR
$888M
$1.29M 1.53%
+300,000
New +$1.72M
WKC icon
23
World Kinect Corp
WKC
$1.81B
$1.28M 1.52%
+50,000
New +$1.36M
CYTK icon
24
Cytokinetics
CYTK
$10B
$1.23M 1.46%
35,000
-15,000
-30% -$612K
OSPN icon
25
OneSpan
OSPN
$610M
$1.23M 1.45%
70,000
+40,000
+133% +$599K

Similar funds

CM Management's Q1 2023 Portfolio in Review

As of Q1 2023, CM Management held 75 positions worth $84.2M, up 0.56% from $83.7M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

CM Management's Q1 2023 filing shows 3 new, 26 increased, 8 reduced and 13 closed positions. Its largest new stake was Sabre: 300,000 shares worth $1.29M. The largest sale was C3.ai, an estimated $1.34M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Industrials and Energy.

  • CM Management's largest Q1 2023 buy was Sabre: 300,000 shares worth $1.29M.
  • CM Management added most to Brookline Bancorp in Q1 2023, an estimated $1.26M increase.
  • CM Management's biggest Q1 2023 reduction was Cytokinetics, cutting an estimated $612K.
  • CM Management fully exited C3.ai in Q1 2023, selling an estimated $1.34M.
  • CM Management's ten largest holdings make up 45% of its $84.2M portfolio in Q1 2023.
  • CM Management opened 3 new positions and closed 13 in Q1 2023.
  • CM Management's portfolio value rose 0.56% quarter-over-quarter to $84.2M.

Based on CM Management's 13F filing for Q1 2023, filed 8 May 2023.